The American Medical Association and the CDC are partners in the "No Time for Flu" campaign that encourages people to get a flu vaccine for this influenza season. The AMA also has prioritized flu vaccinations for Black and Hispanic people because they are more likely to be hospitalized or die from the flu.
The CDC reports that in the past week the number of Americans who got booster doses of the COVID-19 vaccine was about 57% more than the number who received their first dose. As of Thursday, the US had administered 405.4 million COVID-19 vaccine doses and nearly 188.3 million people are fully vaccinated.
Breast cancer survivor and US Olympian Chaunte Lowe, who holds records for the high jump, is the spokesperson for a Susan G. Komen and Eli Lilly campaign addressing inequity in breast cancer care. Black women with breast cancer are more likely than white women to die from the disease, and the campaign will include culturally competent patient navigators who can help Black women understand the health care system and reduce barriers to diagnosis and treatment.
-- Fig CEO Judith Carr-Rodriguez commenting in a Drum report on the changing business landscape.
Bolder Surgical, manufacturer and developer of advanced energy vessel-sealing surgical devices, will be acquired by Hologic in a deal worth $160 million. "We can accelerate growth and improve patient outcomes by leveraging our significant commercial resources and strong relationships with OB-GYNs," said Essex Mitchell, surgical division president at Hologic.
An initial public offering of 5 million shares of common stock, priced by Lucid Diagnostics at $14 per share, is expected to bring in $70 million in proceeds. The offering, closing on or around Oct. 18, included a 30-day option for underwriters to buy 750,000 more shares.
The first patient has been enrolled for CytoSorbent's Safe and Timely Antithrombotic Removal-Ticagrelor trial, which will examine the company's DrugSorb-ATR antithrombotic removal system. "If positive, STAR-T could establish DrugSorb-ATR as an easily implemented solution that addresses a long-standing, frequent, and critical unmet medical need faced by cardiac surgery centers around the world," said principal investigator Bradley Taylor.
Clinical data shows that Veracyte's Percepta Nasal Swab test was able to detect the risk of lung cancer in people with lung nodules. The test demonstrated a 97% sensitivity for classifying patients with a low risk for lung cancer and a 92% specificity for those with an increased risk.
The Cohere TLIF-O porous PEEK implant, used for posterior spine surgery, has been released by NuVasive. The company has also stated that it plans to launch its Cohere TLIF-A implant in this year's fourth quarter.
Health Canada has given a medical device license to Fujifilm Canada for its Aspire Cristalle digital mammography system, allowing it to be sold in the country. The full-field digital mammography system is also able to perform digital breast tomosynthesis.
- Page 1